TMS for PTSD in Youth

Part of paid clinical trials in San Antonio, Texas.

Sponsor
The University of Texas Health Science Center at San Antonio
Study ID
NCT07401225
Status
Recruiting
Apply to this trial

Conditions

  • Post Traumatic Stress Disorder (PTSD)

Eligibility Criteria

Sex
ALL
Age
12 Years - 20 Years
Healthy Volunteers
Not accepted

Interventions

  • MagPro R30 with robotic arm — DEVICE
    TMS will be delivered to the right anterior dorsolateral frontal cortex. The accelerated protocol consists of 1,800 TMS pulses per session, delivered at intensity ranges designed to deliver depth-corrected E-fields of 80-95 volts/meter. The exact intensity will be determined when the participant's treatment plan is developed. Once a patient's TMS treatment plan has been created, it will be used for every treatment session for that participant.

Study Details

The purpose of this study is to test whether transcranial magnetic stimulation, or TMS, is an acceptable and helpful treatment for ongoing symptoms of posttraumatic stress syndrome disorder (PTSD) in 12-20 year olds. Ongoing PTSD refers to symptoms that continue after completing trauma-focused psychotherapy. About 1 in 4 patients need additional help to overcome PTSD after completing psychotherapy. Currently, scientists do not know the best way to help adolescents with persistent PTSD, and this study will test TMS as a possible treatment, and hopefully lead to future studies including more people.

Key Dates

Start date
May 9, 2026
Status verified
Feb 2026
Primary completion
Jun 1, 2027
Completion
Aug 31, 2027

Study Design

Enrollment
20 participants (estimated)
Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT

Arms

  • Experimental: TMS treatment group
    Each treatment visit will take about 1.5 hours. Participants will receive up to 4 TMS treatment sessions during the visit, with each session lasting about 10-minutes. After the TMS sessions, there will be a brief visit with a psychotherapist.

Primary Outcome Measure

Side Effects of TMS treatment [ Time Frame: Day 1 of treatment through Day 30 ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
UT Health Department of PsychiatrySan AntonioTexas78229
Amy Garrett, PhD
[email protected]
2105678189

Find similar trials in San Antonio, TX

By research site
UT Health Department of Psychiatry· San Antonio, TX

Related Studies